Literature DB >> 12939044

Increased resistance of peptides to serum proteases by modification of their amino groups.

Rossella Galati1, Alessandra Verdina, Giuliana Falasca, Alberto Chersi.   

Abstract

The ability of synthetic protein fragments to survive the degradative action of aminopeptidases and serum proteolytic enzymes can be remarkably enhanced by slight modifications at their N-terminal alpha-amino group. This can be achieved by addition of beta-alanine or amino acids of the D-configuration, amino acids which are seldom found in a living organism. These modifications do scarcely modify the chemical and physical properties of the peptides, and should be preferred, especially for in vivo tests, to drastic alterations of peptides as produced by dinitrophenylation or dansylation of the amino groups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939044     DOI: 10.1515/znc-2003-7-819

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  8 in total

1.  Mechanistic insights into the pH-dependent membrane peptide ATRAM.

Authors:  Vanessa P Nguyen; Loganathan Palanikumar; Stephen J Kennel; Daiane S Alves; Yujie Ye; Jonathan S Wall; Mazin Magzoub; Francisco N Barrera
Journal:  J Control Release       Date:  2019-02-11       Impact factor: 9.776

2.  Design, synthesis and bioevaluation of an EphA2 receptor-based targeted delivery system.

Authors:  Elisa Barile; Si Wang; Swadesh K Das; Roberta Noberini; Russell Dahl; John L Stebbins; Elena B Pasquale; Paul B Fisher; Maurizio Pellecchia
Journal:  ChemMedChem       Date:  2014-03-26       Impact factor: 3.466

Review 3.  Targeting the Eph System with Peptides and Peptide Conjugates.

Authors:  Stefan J Riedl; Elena B Pasquale
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

4.  Optimization of peptide arrays for studying antibodies to hepatitis C virus continuous epitopes.

Authors:  Tinashe B Ruwona; Ryan Mcbride; Rebecca Chappel; Steven R Head; Phillip Ordoukhanian; Dennis R Burton; Mansun Law
Journal:  J Immunol Methods       Date:  2013-11-19       Impact factor: 2.303

5.  PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.

Authors:  Roberta Noberini; Sayantan Mitra; Ombretta Salvucci; Fatima Valencia; Srinivas Duggineni; Natalie Prigozhina; Ke Wei; Giovanna Tosato; Ziwei Huang; Elena B Pasquale
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

6.  A broad-spectrum antimicrobial activity of Bacillus subtilis RLID 12.1.

Authors:  Ramya Ramachandran; Ajay Ghosh Chalasani; Ram Lal; Utpal Roy
Journal:  ScientificWorldJournal       Date:  2014-08-11

7.  Clavanin bacterial sepsis control using a novel methacrylate nanocarrier.

Authors:  Amanda C M Saúde; Alicia S Ombredane; Osmar N Silva; João A R G Barbosa; Susana E Moreno; Ana Claudia Guerra Araujo; Rosana Falcão; Luciano P Silva; Simoni C Dias; Octávio L Franco
Journal:  Int J Nanomedicine       Date:  2014-10-31

8.  Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

Authors:  Naomi O Hodgins; Wafa' T Al-Jamal; Julie T-W Wang; Rebecca Klippstein; Pedro M Costa; Jane K Sosabowski; John F Marshall; John Maher; Khuloud T Al-Jamal
Journal:  J Control Release       Date:  2017-04-18       Impact factor: 9.776

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.